Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
-
Shares outstanding
-
264,351,875
-
Total 13F shares
-
28,287,913
-
Share change
-
+5,320,183
-
Total reported value
-
$2,375,235,906
-
Put/Call ratio
-
154%
-
Price per share
-
$83.95
-
Number of holders
-
135
-
Value change
-
+$494,893,838
-
Number of buys
-
100
-
Number of sells
-
36
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q2 2021
As of 30 Jun 2021,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,287,913 shares.
The largest 10 holders included
HHLR ADVISORS, LTD., Cederberg Capital Ltd, BlackRock Inc., Ward Ferry Management (BVI) Ltd, Zeal Asset Management Ltd, Octagon Capital Advisors LP, PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., PRINCIPAL FINANCIAL GROUP INC, and Artal Group S.A..
This page lists
134
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.